Last reviewed · How we verify

NCT06717373: POC

Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis

Recruiting now NA Last updated 12 February 2025
What this trial tests

NA trial testing AutoAS in Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease in 200 participants. Currently enrolling.

Timeline
7 February 2025
Primary endpoint
1 April 2025
1 April 2025

Quick facts

Lead sponsorCaption Health, Inc.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment200
Start date7 February 2025
Primary completion1 April 2025
Estimated completion1 April 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Caption Health, Inc.

Who can join

18 and older, any sex, with Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective clinical trial intended to capture echocardiographic images in patients clinically indicated for an echocardiographic examination using an additional Point of Care Ultrasound device . The images collected will be used to test and possibly validation an AI base Aortic Valve Stenosis algorithm

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Caption Health, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06717373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing